Exogenous TRAIL failed to increase anoikis as observed in a breast cancer model, and finally the proposed mechanism hypothesises that DR5 is activated by cross-linked soluble and membrane-bound TRAIL ligand.128. The gene discussed is TNFSF10; the disease is breast cancer.